Keywords: xoma, drops, cd5, plus, graft-versus-host, disease, announced

Xoma Drops CD5 Plus For Graft-Versus-Host Disease

Article | 09 January 1995

Print This

Xoma has announced that it has discontinued development of its CD5 Plus antibody product for patients with graft-versus-host disease. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in